Aiforia Technologies Plc appointed a new Vice President of Marketing who brings international experience in various commercial positions both in the field of tissue diagnostics and targeted therapies for cancer. As of February 20th, Manuel Ahlsten has been appointed as Vice President of Marketing. In this position, he leads the strategic direction and execution of marketing efforts both in clinical and preclinical settings.

In this role, Manuel aims to accelerate the company's growth strategy by supporting sales efforts and building awareness for Aiforia and its products. Manuel has previously worked in some of the biotechnology companies in the world. He spent several years in the United States working in the global marketing of pathology products for Roche.

Before joining Aiforia, he worked with lung cancer therapies at AstraZeneca as a manager for Nordic sales teams.